{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T09:08:34Z","timestamp":1779700114803,"version":"3.53.1"},"reference-count":28,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics and Practice"],"abstract":"<jats:p>Objective: To develop an individual assessment for patients suffering from medication-related osteonecrosis of the jaw (MRONJ), we developed a scoring system that integrates anamnestic, clinical, and radiological parameters to facilitate the process of therapeutic decisions during MRONJ therapy. Methods: In this study, clinical data as well as diagnostic CT scans from 41 MRONJ patients undergoing antiresorptive therapy were analyzed to develop an Osteonecrosis Scoring Clinical Assessment and Radiological Report (OSCAR). Results: Total OSCAR scores ranged from 4 to 30, with lower scores demonstrating less severe disease progression following a de-escalated therapy. OSCAR scores above 15 were associated with higher bone density and an increased need for surgical intervention, with 70% of Denosumab and 71% of bisphosphonate patients requiring surgical intervention. Conclusions: Patients with an OSCAR below 12 were unlikely to require multiple surgical interventions. Since OSCAR parameters are routinely collected during hospitalization, this opens the possibility for future AI-assisted patient assessment and treatment planning.<\/jats:p>","DOI":"10.3390\/clinpract16050094","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T08:06:26Z","timestamp":1779696386000},"page":"94","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["OSCAR-Assessing Individual Risk Profiles of MRONJ Patients"],"prefix":"10.3390","volume":"16","author":[{"given":"Felix","family":"Pitka","sequence":"first","affiliation":[{"name":"Clinic for Maxillofacial Surgery, University Medical Center Goettingen, 37075 Goettingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"B\u00f6hrnsen","sequence":"additional","affiliation":[{"name":"Clinic for Maxillofacial Surgery, University Medical Center Goettingen, 37075 Goettingen, Germany"},{"name":"Department of Maxillo-Facial-Surgery, Medical University of Luebeck, 23562 Luebeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"ref_1","unstructured":"Schiegnitz, E., Al-Nawas, B., Hoefert, S., Otto, S., Pautke, C., Ristow, O., Voss, P., and Gr\u00f6tz, K.A. (2017). S3-Leitlinie Antiresorp-Tiva-Assoziierte Kiefernekrosen [2017], AWMF."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral FracturesResults From the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis","volume":"333","author":"Liberman","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: A systematic review","volume":"24","author":"McGowan","year":"2018","journal-title":"Oral Dis."},{"key":"ref_10","first-page":"1","article-title":"Navigating the complexities and controversies of medication-related osteonecrosis of the jaw (MRONJ): A critical update and consensus statement","volume":"124","author":"Coropciuc","year":"2024","journal-title":"Acta Chir. Belg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1016\/j.bjoms.2021.03.006","article-title":"Systematic review of medication related osteonecrosis of the jaw (MRONJ) in patients undergoing only antiangiogenic drug therapy: Surgery or conservative therapy?","volume":"60","author":"Sacco","year":"2022","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws\u20142022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_14","first-page":"e302","article-title":"Surgical treatment vs. conservative treatment in intravenous bisphosphonate-related osteonecrosis of the jaws. Systematic review","volume":"9","author":"Figueiredo","year":"2017","journal-title":"J. Clin. Exp. Dent."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.jcms.2015.07.035","article-title":"Surgical treatment of bisphosphonate-associated osteonecrosis: Prognostic score and long-term results","volume":"43","author":"Reich","year":"2015","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5125\/jkaoms.2018.44.5.225","article-title":"Clinical characteristics and recurrence-related factors of medication-related osteonecrosis of the jaw","volume":"44","author":"Kang","year":"2018","journal-title":"J. Korean Assoc. Oral Maxillofac. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5125\/jkaoms.2018.44.4.174","article-title":"Prognostic factors for outcome of surgical treatment in medication-related osteonecrosis of the jaw","volume":"44","author":"Shin","year":"2018","journal-title":"J. Korean Assoc. Oral Maxillofac. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jcms.2014.01.012","article-title":"A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography","volume":"42","author":"Hamada","year":"2014","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"20190132","DOI":"10.1259\/dmfr.20190132","article-title":"Antiresorptive drug-related changes of the mandibular bone densitiy in medication-related osteonecrosis of the jaw patients","volume":"48","author":"Heim","year":"2019","journal-title":"Dentomaxillofac. Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-Induced Exposed Bone (Osteonecrosis\/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_21","unstructured":"Sch\u00e4fer, C. (2020). Assoziation von Entz\u00fcndungsparametern (CRP und Leukozytenzahl) mit der Rezidivwahrscheinlichkeit der Medikamenten-Assoziierten Kiefernekrose nach Operativer Sanierung [Internet], FAU Erlangen-N\u00fcrnberg. Available online: https:\/\/open.fau.de\/server\/api\/core\/bitstreams\/792a5360-d7b0-454a-abb0-3099061fb101\/content."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible Association between Diabetes and Bisphosphonate-Related Jaw Osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2214\/ajr.181.3.1810743","article-title":"A Rosetta Stone for Coronary Calcium Risk Stratification: Agatston, Volume, and Mass Scores in 11,490 Individuals","volume":"181","author":"Rumberger","year":"2003","journal-title":"Am. J. Roentgenol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.oraloncology.2014.02.013","article-title":"Bisphosphonates inhibit bone remodeling in the jaw bones of rats and delay healing following tooth extractions","volume":"50","author":"Jabbour","year":"2014","journal-title":"Oral Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40902-021-00310-w","article-title":"Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment","volume":"43","author":"Lee","year":"2021","journal-title":"Maxillofac. Plast. Reconstr. Surg."},{"key":"ref_26","unstructured":"Singh, B., Goyal, A., and Patel, B.C. (2025). C-Reaktive Protein: Clinical Relevance and Interpretation. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2106\/JBJS.J.00160","article-title":"Hounsfield Units for Assessing Bone Mineral Density and Strength: A Tool for Osteoporosis Management","volume":"93","author":"Schreiber","year":"2011","journal-title":"J. Bone Jt. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"On, S.W., Cho, S.W., Byun, S.H., and Yang, B.E. (2021). Various Therapeutic Methods for the Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ) and Their Limitations: A Narrative Review on New Molecular and Cellular Therapeutic Approaches. Antioxidants, 10.","DOI":"10.3390\/antiox10050680"}],"container-title":["Clinics and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-7283\/16\/5\/94\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T08:56:24Z","timestamp":1779699384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-7283\/16\/5\/94"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["clinpract16050094"],"URL":"https:\/\/doi.org\/10.3390\/clinpract16050094","relation":{},"ISSN":["2039-7283"],"issn-type":[{"value":"2039-7283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}